Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 46

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 2
Chunk 46
---
 and operating cash usage can influence both the absolute level of interest income and its variability
across reporting periods. Our policy treats highly liquid investments with original maturities of three months or less as cash equivalents.

Interest
Expense

Interest
expense primarily arises from financing arrangements recorded on our balance sheet (including notes payable), and will vary based on
outstanding principal, effective interest rates, and any amortization of related financing costs. Changes in borrowings or the terms
of such obligations can therefore impact period-over-period comparability.

25

Results
of Operations

Three
Months Ended September 30, 2025 Compared to the Three Months Ended September 30, 2024

The
period-to-period comparisons of our historical results are not necessarily indicative of the results that may be expected in the future.
The results of operations for the three months ended September 30, 2025 and September 30, 2024, have been derived from the condensed
consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

    For the Three Months Ended  
    Variance 

    September 30,  2025  
    September 30,  2024  
    September 30,  2025  
    September 30,  2024 
  
    Expenses: 

    Research and development 
    $816,697  
    $91,911  
    $724,786  
     789%
  
    General and administrative 
     1,480,356  
     401,636  
     1,078,720  
     269%
  
    Total operating expenses 
     2,297,053  
     493,547  
     1,803,506  
     365%

    Loss from operations 
     (2,297,053) 
     (493,547) 
     (1,803,506) 
     365%

    Other Income (Expenses): 

    Interest income 
     10,212  
     23  
     10,189  
     44300%
  
    Gain on change in fair value of derivative liability 
     -  
     9,885  
     (9,885) 
     -100%
  
    Interest expense 
     (1,193) 
     (107,382) 
     106,189